BOT 5.26% 36.0¢ botanix pharmaceuticals ltd

Ann: Botanix Announces Top Line BTX 1204 Atopic Dermatitis Data, page-127

  1. 2,353 Posts.
    lightbulb Created with Sketch. 448
    Can't believe we still have an enterprise value of c.$30m - what do we currently have that is worth $30m?

    Acne - the Ph2 F-up looks even worse now, and they want to spend the remaining $30m to take it to Ph3 ?????

    Microbial - can we have any confidence that is going in the right direction?

    I'm 85% down on BOT, no point in selling but I will on June 30 as I have some CGT I can wipe out with the losses but that is the only silver lining to this ugly, black cloud.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.